BBOT
BridgeBio Oncology Therapeutics, Inc.
3.90$
-1.3%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Cash Flow
BridgeBio Oncology Therapeutics, Inc. (BBOT) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -114 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| – | – | -52 | -0.8 | -114 | |
| – | – | 0.1 | 0.2 | 0.6 | |
| – | – | 16 | 0.3 | 5.9 | |
| – | – | -3.9 | -0.1 | 6.4 | |
| 0.0 | 0.0 | 0.4 | 0.0 | 0.6 | |
| – | – | -2.8 | -184 | 73 | |
| – | – | 55 | 186 | 383 | |
| – | – | 0.2 | 1.7 | 343 | |
| – | – | -52 | -0.8 | -115 |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.